CP-383

· Tasca Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-383, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]